Latest Advisory

  • FDA Advisory No. 2017-252 || Public Health Warning Against the Use of Unnotified Cosmetic Products (Batch 62)

    FDA Advisory No. 2017-252 || Public Health Warning Against the Use of Unnotified Cosmetic Products (Batch 62)

    Read more

  • FDA Advisory No. 2017-236 || Public Health Warning Against the Use of Unregistered Household/Urban Pesticide Products (Batch 12)

    FDA Advisory No. 2017-236 || Public Health Warning Against the Use of Unregistered Household/Urban Pesticide Products (Batch 12)

    Read more

  • FDA Advisory No. 2017-253 || Re-certification of Contraceptive Products Pursuant to the Resolution of the Supreme Court dated 25 April 2017 on the Omnibus Motion filed by the Food and Drug Administration on 10 October 2016 in Alliance for the Family Found

    FDA Advisory No. 2017-253 || Re-certification of Contraceptive Products Pursuant to the Resolution of the Supreme Court dated 25 April 2017 on the Omnibus Motion filed by the Food and Drug Administration on 10 October 2016 in Alliance for the Family Found

    Read more

  • PUBLIC SERVICE ANNOUNCEMENT PO MULA SA FOOD AND DRUG ADMINISTRATION

    PUBLIC SERVICE ANNOUNCEMENT PO MULA SA FOOD AND DRUG ADMINISTRATION

    Read more

  • MARCHING ORDERS

    MARCHING ORDERS

    Read more

  • FDA Advisory No. 2017-251 || Voluntary Recall of QIAamp DSP Virus Kit  CE

    FDA Advisory No. 2017-251 || Voluntary Recall of QIAamp DSP Virus Kit CE

    Read more

  • FDA Advisory No. 2017-244 || Public Health Warning Against the Purchase and Consumption of the following Unregistered Food Supplements and Food Products:

    FDA Advisory No. 2017-244 || Public Health Warning Against the Purchase and Consumption of the following Unregistered Food Supplements and Food Products:

    Read more

  • FDA Advisory No. 2017-243-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Pekeng Bersyon ng Dydrogesterone (Duphaston) 10 mg Film-coated Tablet

    FDA Advisory No. 2017-243-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Pekeng Bersyon ng Dydrogesterone (Duphaston) 10 mg Film-coated Tablet

    Read more

  • FDA Advisory No. 2017-243 || Public Health Warning Against the Purchase and Use of the Counterfeit Version of Dydrogesterone (Duphaston) 10 mg Film-coated Tablet

    FDA Advisory No. 2017-243 || Public Health Warning Against the Purchase and Use of the Counterfeit Version of Dydrogesterone (Duphaston) 10 mg Film-coated Tablet

    Read more

  • FDA Advisory No. 2017-242-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Hindi Rehistradong Gamot na:

    FDA Advisory No. 2017-242-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Hindi Rehistradong Gamot na:

    Read more

  • FDA Advisory No. 2017-242 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:

    FDA Advisory No. 2017-242 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:

    Read more

  • FDA sets first regulatory fair on Aug. 17-18 at PICC

    FDA sets first regulatory fair on Aug. 17-18 at PICC

    Read more

  • FDA holds first regulatory exhibit

    FDA holds first regulatory exhibit

    Read more

  • A ‘new’ FDA

    A ‘new’ FDA

    Read more

  • FDA Advisory No. 2017-250 || Public Health Warning Against the Purchase and Consumption of the following Unregistered Food Products and Food Supplement:

    FDA Advisory No. 2017-250 || Public Health Warning Against the Purchase and Consumption of the following Unregistered Food Products and Food Supplement:

    Read more

  • FDA Advisory No. 2017-249 || Public Health Warning Against the Purchase and Consumption of the following Unregistered Food Products and Food Supplements:

    FDA Advisory No. 2017-249 || Public Health Warning Against the Purchase and Consumption of the following Unregistered Food Products and Food Supplements:

    Read more

  • FDA Advisory No. 2017-247 || Public Health Warning Against Unapproved  Advertisement and Promotion of Unregistered V-MORINGA Capsule  with Therapeutic Claims

    FDA Advisory No. 2017-247 || Public Health Warning Against Unapproved Advertisement and Promotion of Unregistered V-MORINGA Capsule with Therapeutic Claims

    Read more

  • FDA Advisory No. 2017-246 || Public Health Warning Against the Purchase and Consumption of the following Unregistered Food Supplements:

    FDA Advisory No. 2017-246 || Public Health Warning Against the Purchase and Consumption of the following Unregistered Food Supplements:

    Read more

  • FDA Advisory No. 2017-245 || Public Health Warning Against the following Unregistered Food Supplements with their Corresponding Unapproved and Misleading Advertisements and Promotion:

    FDA Advisory No. 2017-245 || Public Health Warning Against the following Unregistered Food Supplements with their Corresponding Unapproved and Misleading Advertisements and Promotion:

    Read more

  • FDA Advisory No. 2017-241 || Public Health Warning Against the Purchase and Consumption of the following Unregistered Food Products and Food Supplements:

    FDA Advisory No. 2017-241 || Public Health Warning Against the Purchase and Consumption of the following Unregistered Food Products and Food Supplements:

    Read more

FDA to commence re-certification process of contraceptive products.

The FDA will issue a formal announcement for the commencement of the recertification process of the listed contraceptive products on Monday, 21 August, in compliance with the Supreme Court's Decision in Alliance for the Family Foundation Inc., vs. Sec. Garin et al.

The announcement will contain the following:
(1) list and details of the contraceptive products (i.e., generic and brand name [if any], dosage form and strength, and registration numbers) for recertification,
and (2) the mechanics for submitting comments/petitions in support of, or in opposition to [with supporting evidence], the recertification, by the public, and concerned groups/individuals.

THE 1st FDA REGULATORY ADVOCACY FAIR, and Back- to-BACK QUALIFIED PERSONS in INDUSTRY REGULATORY AFFAIRS (QPIRA) TRAININGS ON  17-18 AUGUST 2017 at PICC, PICC COMPLEX, ROXAS BOULEVARD, PASAY CITY

For                     :   ALL FDA QPIRA REGISTRANTS

From                  :   FDA ACADEMY

Subject              :   THE 1st FDA REGULATORY ADVOCACY FAIR, and Back- to-BACK QUALIFIED PERSONS in INDUSTRY REGULATORY AFFAIRS (QPIRA) TRAININGS ON  17-18 AUGUST 2017 at PICC, PICC      COMPLEX, ROXAS BOULEVARD, PASAY CITY

 

Please be informed that slots for the four (4) QPIRA sessions (CDRR, CDRRHR, CCRR, and CFRR) are now officially CLOSED.

The FDA Academy is now finalizing the list of confirmed participants for the four QPIRA sessions. All registrants who have made the corresponding fees but are yet to be confirmed for the said QPIRA trainings are informed that you can no longer be accommodated for 17-18 August 2017 but are enlisted participants for the next QPIRA trainings to be conducted by the FDA Academy. 

1st FDA Regulatory Advocacy Fair, and Back-to-Back Qualified Persons in Industry Regulatory Affairs (QPIRA) Training on 17-18 August 2017 at PICC, PICC Complex, Roxa Boulevard, Manila

Relative to the FDA Memorandum Circular No. 2017-002 dated 19 July 2017 entitled "1st FDA Regulatory Advocacy Fair, and Back-to-Back Qualified Persons in Industry Regulatory Affairs (QPIRA) Trainings", all FDA Clients, who are waitlisted for the FDA Academy - QPIRA Trainings, are notified that the FDA Academy is now sending assessment form/slip for the corresponding payment of fees.

 

to continue reading download attachment...

THE 1st FDA REGULATORY ADVOCACY FAIR, and Back- to-BACK QUALIFIED PERSONS in INDUSTRY REGULATORY AFFAIRS (QPIRA) TRAININGS ON  17-18 AUGUST 2017 at PICC, PICC COMPLEX, ROXAS BOULEVARD, PASAY CITY

For                     :   ALL FDA QPIRA REGISTRANTS

From                  :   FDA ACADEMY

Subject              :   THE 1st FDA REGULATORY ADVOCACY FAIR, and Back- to-BACK QUALIFIED PERSONS in INDUSTRY REGULATORY AFFAIRS (QPIRA) TRAININGS ON  17-18 AUGUST 2017 at PICC, PICC COMPLEX, ROXAS BOULEVARD, PASAY CITY

ALL QPIRA ATTENDEES FOR THE 17-18 AUGUST 2017 BACK-to-BACK TRAININGS AT PICC ARE REMINDED TO BRING AND PRESENT THE FOLLOWING AT THE REGISTRATION AREA:

  1. VALID ID WITH PICTURE
  2. ORIGINAL COPY OF NOTARIZED AFFIDAVIT WITH UNDERTAKING
  3. CONFIRMATION SLIP WITH FOOD STUB

FAILURE TO SUBMIT ANY OF THE ABOVE-STATED REQUIREMENTS

WILL BE A GROUND TO DENY ENTRY AT THE VENUE.

REGISTRATION STARTS AT 7 A.M AND COURSE SESSION WILL START AT EXACTLY 8:30 A.M.

LATE COMERS WILL NOT BE ACCEPTED AFTER 8:30 AM. AND THEIR REGISTRATION FEE WILL BE AUTOMATICALLY FORFEITED.

RELOCATION AND OPERATION OF FDAC AT THE 4TH FLOOR, CIVIC PRIME BUILDING, CIVIC DRIVE, FILINVEST CORPORATE CITY, ALABANG,  MUNTINLUPA CITY STARTING 24 JULY 2017 (MONDAY)

In connection to the FDA Advisory No. 2017-204 titled “Relocation of the Food and Drug Action Center (FDAC)”, all transactions in the FDA PAIR Unit at Room 106 will be entertained at new FDAC Office located at Civic Prime Bldg., Civic Drive, Alabang Muntinlupa City, starting on Monday, July 24, 2017.

For your information, guidance and compliance.

Attachments:
Download this file (FDAC- Announcement.pdf)FDAC- Announcement.pdf

Share Us on

Submit to FacebookSubmit to Google PlusSubmit to Twitter